REINVENTING MEDICINE AND HEALTHCARE: THE FUTURE OF PHARMACEUTICAL FIRMS AND DRUGS
The pharmaceutical industry faces rising complexity and expectations. As development costs soar amid slowing new drug approvals, pharma must harness technology and data-driven insights to boost R&D productivity, access, and personalization.Medicine development remains high-risk and expensive, now costing an average $2.6 billion per approved drug....